|
CCDC66 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.760300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.040220E-01 |
| Normal-vs-Stage2 |
4.205200E-01 |
| Normal-vs-Stage3 |
2.932600E-01 |
| Normal-vs-Stage4 |
8.219800E-01 |
| Stage1-vs-Stage2 |
8.746000E-01 |
| Stage1-vs-Stage3 |
1.510160E-02 |
| Stage1-vs-Stage4 |
3.753600E-01 |
| Stage2-vs-Stage3 |
2.043400E-01 |
| Stage2-vs-Stage4 |
4.879600E-01 |
| Stage3-vs-Stage4 |
8.343400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.149990E-01 |
| Normal-vs-AfricanAmerican |
9.501900E-02 |
| Normal-vs-Asian |
5.198400E-01 |
| Caucasian-vs-AfricanAmerican |
5.539800E-01 |
| Caucasian-vs-Asian |
6.817200E-01 |
| AfricanAmerican-vs-Asian |
7.697400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.402000E-01 |
| Normal-vs-Female |
1.755960E-02 |
| Male-vs-Female |
7.580200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.660600E-01 |
| Normal-vs-Extreme_Weight |
4.512600E-01 |
| Normal-vs-Obese |
2.621200E-01 |
| Normal-vs-Extreme_Obese |
9.477200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.529200E-01 |
| Normal_Weight-vs-Obese |
9.187200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.499000E-01 |
| Extreme_Weight-vs-Obese |
6.398200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.551600E-01 |
| Obese-vs-Extreme_Obese |
6.091400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.308000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.825570E-02 |
| Normal-vs-Age(61-80Yrs) |
3.108800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.678400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.147000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.459000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.496190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.350400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.981600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.771000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.392800E-04 |
| Normal-VS-Type2 PRCC |
4.701800E-02 |
| Normal-VS-KIRP CIMP |
1.129370E-01 |
| Normal-VS-Unclassified PRCC |
2.203800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.94559999619781E-08 |
| Type1 PRCC-VS-KIRP CIMP |
2.099600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.246000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.541800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.622270E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.823800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.315000E-01 |
| Normal-vs-N1 |
8.111000E-01 |
| Normal-vs-N2 |
3.459900E-02 |
| N0-vs-N1 |
6.412600E-01 |
| N0-vs-N2 |
2.261400E-01 |
| N1-vs-N2 |
1.611160E-01 |
|
|
